Clinical objective study on the prevention and treatment of spleen pain (metabolic syndrome) with the method of resolving Shaoyang (Lidan Huatan Huoxue Fang)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003885

Enrollment

Unknown

Registered

2020-09-02

Start date

2021-01-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Control group, Western medicine group:Healthy life behavior intervention, western medicine treatment

Experimental group, Integrated traditional Chinese and Western medicine group:Healthy life behavior intervention, western medicine treatment + Lidan Huatan Huoxue Decoction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with metabolic syndrome who meet the above diagnostic criteria of Western medicine. 2. Patients aged between 18 and 70 years old are not limited to men and women. 3. Patients with informed consent signed the informed consent form and took the test voluntarily.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Type 1 diabetes mellitus, gestational diabetes mellitus and other types of diabetes mellitus, secondary hypertension and / or hyperlipidemia. 3. Patients with serious heart, liver, kidney complications or other serious primary diseases, mental illness.

Design outcomes

Primary

Measure	Time frame
routine blood test;Glucose metabolism index;blood pressure;the waist;Objective indicators of four diagnostic methods in traditional Chinese Medicine;blood fat;urinalysis;Liver and kidney function;Stool routine;electrocardiogram;	—

Countries

China

Contacts

Public ContactWang Bing

Shanghai Sixth People's Hospital

ebingliver@163.com+86 18930177667

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026